Sodium Chloride Injection (250 mL) Supply

The contract calls for the supply of FDA-approved, sterile Sodium Chloride Injection, USP, in 250 mL flexible bags, manufactured and packaged to meet stringent USP standards, MMS NO. 1 specifications, and DLA labeling requirements. The product must be suitable for intravenous use and fully compliant with federal regulatory and procurement guidelines for medical supplies within the Department of Defense. All lots must be sterile, pyrogen-free, and consistently meet the quality benchmarks set by the United States Pharmacopeia to ensure patient safety and clinical efficacy. The solicitation is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing and is structured as a subcontract through the Medical Supply Chain Pharm FSA. Responses are due by August 3, 2026, with performance expected to support logistics operations centered at Fort Bragg, North Carolina, under the 28310 zip code. The contract is managed by the Department of Defense and will be administered through the DLA network, requiring strict adherence to packaging, labeling, and documentation standards mandated by DLA to ensure seamless integration into military medical supply chains.